Matches in Wikidata for { <http://www.wikidata.org/entity/Q95056281> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q95056281 description "clinical trial" @default.
- Q95056281 description "ensayo clínico" @default.
- Q95056281 description "ensayu clínicu" @default.
- Q95056281 description "klinisch onderzoek" @default.
- Q95056281 description "клінічне випробування" @default.
- Q95056281 description "临床试验" @default.
- Q95056281 name "A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC" @default.
- Q95056281 name "A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC" @default.
- Q95056281 type Item @default.
- Q95056281 label "A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC" @default.
- Q95056281 label "A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC" @default.
- Q95056281 prefLabel "A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC" @default.
- Q95056281 prefLabel "A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC" @default.
- Q95056281 P1132 Q95056281-70E7317C-BC0C-4EF7-B2A4-7AB63B79B898 @default.
- Q95056281 P1476 Q95056281-B8DA5D73-8843-46BA-9BDA-A0BA600D6647 @default.
- Q95056281 P2899 Q95056281-C57E4865-2517-44AE-96D3-4B04F3FD0D37 @default.
- Q95056281 P3098 Q95056281-3A9BA23D-2027-4136-A184-DDC82E5E6CE8 @default.
- Q95056281 P31 Q95056281-BD793698-35BE-4993-AE2C-BF81BC54D8BE @default.
- Q95056281 P580 Q95056281-EB05F770-9B89-4A24-BC4D-E5558301D9F4 @default.
- Q95056281 P582 Q95056281-0064F498-31DF-420F-838D-B230E9F78420 @default.
- Q95056281 P6099 Q95056281-5473B97C-2613-4BBB-9C19-5292C180B1A1 @default.
- Q95056281 P8005 Q95056281-1E65FFA4-730E-46F0-8470-C092F1736E0C @default.
- Q95056281 P8363 Q95056281-88E8B386-F180-45C3-9EED-F79BEB225F22 @default.
- Q95056281 P1132 "+86" @default.
- Q95056281 P1476 "A Phase II Study of Cemiplimab, an Anti-PD-1 Monoclonal Antibody, and ISA101b Vaccine in Patients With Recurrent/Metastatic HPV16 Positive Oropharyngeal Cancer Who Have Experienced Disease Progression With Prior Anti-PD-1 Therapy" @default.
- Q95056281 P2899 "+18" @default.
- Q95056281 P3098 "NCT04398524" @default.
- Q95056281 P31 Q30612 @default.
- Q95056281 P580 "2020-11-01T00:00:00Z" @default.
- Q95056281 P582 "2022-12-30T00:00:00Z" @default.
- Q95056281 P6099 Q42824440 @default.
- Q95056281 P8005 Q76649614 @default.
- Q95056281 P8363 Q78089383 @default.